Patients on chronic semaglutide therapy may experience reduced intrinsic factor production or altered intestinal transit, potentially lowering B12 bioavailability over time
At this time, there is not enough scientific evidence to consider it safe for use during pregnancy or breastfeeding, so avoiding it during these stages is generally recommended
Higher doses of semaglutide were tested specifically for weight management
Considering that the number of individuals suffering from cancer-related disorders is growing by the day and since conventional therapies typically have a troubling number of deficiencies and drawbacks, it is critical to establish a new therapeutic strategy
Weight loss or metabolic shifts from GLP-1 drugs might affect your menstrual cycle
A: The side effects of Contrave that were most commonly reported are constipation, vomiting, diarrhea, nausea, dizziness, headaches, dry mouth and insomnia